Auto Scroll |
Clear |
Close
Analyst / Investor Event & Interim Results
- Opening Remarks & Introduction
- Market Context - AI-enabled drug discovery
- The Benevolent AI Business Model
- Animated Benevolent Platform Video
- The BenevolentAI Approach & our Technology
- Drug Discovery & Pipeline Review
- Interim Results - H1 Operational & Financial Review
- Closing Remarks and Outlook
- Q&A
Loading...Please Wait
Loading...Please Wait
|